Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients.
Guro Elisabeth LindMarianne GuribyTerje AhlquistIsrar HussainMarine JeanmouginKjetil SøreideHartwig KørnerRagnhild A LotheOddmund NordgårdPublished in: Clinical epigenetics (2017)
Colon cancer patients with high sentinel lymph node methylation of the analyzed epigenetic biomarker panel had an inferior prognosis, although not significant in multivariate analyses. Occult metastases in TNM stage II patients that experienced relapse were not detected.